Independent OCT Registry on Very Late Bioresorbable Scaffold Thrombosis

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

December 2, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

July 25, 2017

Conditions
Coronary ThrombosisTomography, Optical CoherenceDrug-Eluting Stents
Interventions
DEVICE

Bioresorbable vascular scaffold

"No study specific procedures will be applied. Optical coherence tomography recordings at the time of very late scaffold thrombosis were obtained during clinical routine with one of the commercially available and approved optical coherence tomography consoles and catheters. The analysis will be conducted at the Core laboratory at Bern University Hospital, Bern, Switzerland using a systematic and validated approach.~Every participant will be coded by getting a number (pseudonym) in the local institutes. In the Core Laboratory, data will be further coded to ensure anonymity of the participants."

Trial Locations (19)

Unknown

5th Medical Department with Cardiology, Kaiser Franz Josef Hospital, Vienna

Department of Cardiology, University Hospital Leuven, Leuven

Cardiology Department, CHU Clermont-Ferrand, Clermont-Ferrand

Department of Cardiology, University Hospital Caremeau, Nîmes

Department of Cardiology, CH F Mitterand, Pau Université Cedex, France., Pau

Department of Cardiovascular Medicine, Hypertension and Heart Failure Unit, Health Innovation Lab (Hi-Lab) Clinique Pasteur, Toulouse

Department of Cardiology, University of Giessen, Giessen

Department of Cardiology, Asklepios Klinik St. Georg, Hamburg

Heart Center, Segeberger Kliniken GmbH, Academic Teaching Hospital of the Universities of Kiel, Kiel

Deutsches Herzzentrum München, Technische Universität München,, Munich

Cardiology Division, Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Chai Wan

Cardiology Division, Department of Medicine, Queen Elizabeth Hospital, Kowloon

Cardiology Division, Bolognini Hospital, Seriate

Academic Medical Center, University of Amsterdam, Amsterdam

Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands., Rotterdam

Department of Cardiology, University Medical Centre Utrecht, Utrecht

Cardiac Department, National University Heart Centre, Singapore

Hospital Universitari de Bellvitge, Institut d' Investigació Biomèdica de Bellvitge, Universitat de Barcelona, L' Hospitalet de Llobregat, Spain., Barcelona

Department of Cardiology, Stadtspital Triemli, Zurich

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT03180931 - Independent OCT Registry on Very Late Bioresorbable Scaffold Thrombosis | Biotech Hunter | Biotech Hunter